Type 2 Diabetes Mellitus
Conditions
Brief summary
The investigators plan an R33 phase trial in which 120 persons with type 2 diabetes (T2DM) will be randomized (using a 1:1 ratio) to education alone (Ed) on following a carbohydrate restricted diet for T2DM, or this same education content with added mindful eating/Mindfulness-Based Intervention components (Ed+MBI).
Detailed description
The investigators will randomize 120 persons with T2DM in a 1:1 ratio to a nutrition education alone arm (Ed n=60) vs. a nutrition education with mindfulness-based intervention components (Ed+MBI n=60) arm and follow them for 12 months. The interventions will be provided in a weekly group setting, with about 10 to 12 persons per group. Some educational intervention components will be delivered using a smartphone app. After the 12-week initial intervention, the investigators will re-randomize participants using an adaptive intervention design to receive low, medium, or high intensity maintenance training, depending on level of adherence achieved during the initial intervention period. Follow-up assessments will be performed at 3, 6, 9, and 12 months. The investigators will address the following specific aims: 1. Test the hypothesis that the Ed+MBI arm will have better dietary adherence than the Ed arm. 2. Test whether our proposed behavioral mechanisms (e.g. decreased eating in response to cravings or difficult emotions) predict dietary adherence. 3. Obtain preliminary assessment of intervention effects on clinical outcomes This is the second phase of a two-phase study. Pilot testing has been completed in the first phase (R61). The focus of the second phase (R33) is on comparing dietary adherence between the Ed only and ED + MBI arms over a 12-month period. This phase will also include employing an adaptive intervention design in the post-treatment phase to test optimization of the maintenance intervention (i.e. assigning maintenance intensity/dose based on how a participant is doing). The maintenance phase intensities will be assessed to provide preliminary data for planning future trials. The primary analysis focus of this phase will be on the comparing the groups formed by the initial randomization to Ed versus Ed + MBI. The investigators will use fingerstick blood ketone measures, which provide an objective measure of whether the target levels of carbohydrate restriction have been attained, as our primary adherence outcome measure. This will be supplemented by 24-hour diet recall measures of carbohydrate consumption. Important secondary outcome measures will include clinical measures such as glycosylated hemoglobin and behavioral measures such as frequency of eating in response to food cravings.
Interventions
Education for carbohydrate-restricted diet
Mindful eating app use plus group sessions to learn mindfulness
Sponsors
Study design
Masking description
Blood tests at LabCorp and 24-hour dietary recall interviews are done by research assistants blinded to treatment assignment.
Eligibility
Inclusion criteria
1. History of T2DM mellitus. 2. HbA1c ≥ 6.5% and \< 12.0% at screening. 3. Experience food-related cravings most days of the week and eat in response to these cravings regularly. 4. Aged 18 years old and older. 5. Able to engage in light physical activity. 6. Willing and able to participate in the interventions including appropriate participation in the group setting. 7. Have smartphone and are willing to use it on a regular basis for data collection. 8. Ability to speak English.
Exclusion criteria
1. Unable to provide informed consent. 2. A substance abuse, mental health, or medical condition that, in the opinion of investigators, will make it difficult for the potential participant to participate in the intervention, that may need immediate changes in medical management that will affect study outcome measures, or that may require important adaptations in the study diet. 3. Pregnant or planning to get pregnant in the next 12 months, breastfeeding or less than 6 months post-partum. 4. Current use of weight loss medications, such as Alli or amphetamine-based drugs that may affect weight. 5. Planned or history of weight-loss (bariatric) surgery, or other intestinal surgeries that cause malabsorption. These are likely to change study outcome measures, making it difficult to distinguish the effects of the intervention program, or require extensive tailoring of the diet intervention. 6. Currently enrolled in a weight loss program, such as Weight Watchers or a self-help group such as Overeaters Anonymous, or have unalterable plans to enroll in one of these programs in the next year; using a ketogenic low carbohydrate diet in the past 6 months with advice from a health care professional; or use of a mindful eating program with guidance from a professional in the past 6 months or have ever used the study mindful-eating app. 7. Vegan or vegetarian. 8. Unwilling to do regular blood testing at home for glucose or ketone monitoring.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Diet Adherence Between Intervention Arms as Measured by % of Ketones >= 0.5 mmol/L | Measures from ketone measure initiation (week 5) to 12 months. Ketones were measured daily over 7 days at 5 study timepoints: 5 weeks, 3, 6, 9, and 12 months. | Percent of participant ketone measures \> or = 0.5 mmol/L during trial, by study arm |
| Diet Adherence Between Intervention Arms as Measured by % of Participants in Each Arm With < 50 Grams/Day of Non-fiber Carbohydrate on 24- Hour Diet Recall | Average of three measures, done at 3, 6 and 12 months | Average percent of participant measures with consumption of \< 50 grams/day of non-fiber carbohydrate (from 24-hour diet recall) by arm. Each participant was assigned a % of up to three measures reporting \< 50 grams/day of non-fiber carbohydrate consumption, and this percent was averaged across each arm. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Emotion-related Eating | change from baseline to 12 months | change in emotion-related eating as measured by the Coping subscale of the Palatable Eating Motives Scale (PEMS). The coping subscale ranges from 1 to 5 (based on a mean of 4 items), with higher values indicating more emotion-related eating (the intervention aimed to lower this score--lower scores represent improvement). |
| Glycemic Control--HbA1c | change from baseline to 12 months | Change in Hemoglobin A1c from baseline to 12 months with study arm |
| Frequency of Eating in Response to Cravings | Change from baseline to 12 months | Frequency of eating in response to cravings (indulgence) using ecological momentary assessment (EMA), operationalized as the percent of solicited occasions when a participant reported eating in response to cravings (rather than in response merely to hunger). Participants received 18 queries about eating in response to cravings over 3 days. Participants had to respond to at least 9 queries to have adequate data completeness for analysis. Frequency of eating in response to cravings is the proportion (scaled as a percent) of queries that participants responded to with responses that reported eating in response to cravings. |
| Diet Adherence Between Intervention Arms as Measured by Mean Grams of Non-fiber Carbohydrate Consumed Per Day From 24- Hour Diet Recall | From 3 to 12 months, using measures done at 3, 6, and 12 months | Mean grams of non-fiber carbohydrate consumed per day (from 24-hour diet recall) during trial. We calculated average grams of non-fiber consumed per day across up to three measures during the trial for each participant, and this was averaged across arms. |
| Salzburg Stress Eating Scale | change from baseline to 12 months | Change in stress-related eating as measured by Salzburg Stress Eating Scale. Range is from 1 to 5. Higher scores indicate greater stress-related eating. |
| Weight Change | change from baseline to 12 month weight data | Body mass in kilograms (kg) from baseline to 12 months |
Countries
United States
Contacts
University of California, San Francisco
University of California, San Francisco
Baseline characteristics
| Characteristic | — |
|---|---|
| Age, Continuous | 58.4 years STANDARD_DEVIATION 10.1 |
| Hemoglobin A1c | 8.54 % of hemaglobin with glycosolation STANDARD_DEVIATION 1.5 |
| Race/Ethnicity, Customized Asian or Pacific Islander | 11 Participants |
| Race/Ethnicity, Customized Black | 14 Participants |
| Race/Ethnicity, Customized Latino/a | 10 Participants |
| Race/Ethnicity, Customized Native American | 0 Participants |
| Race/Ethnicity, Customized Other or more than one | 4 Participants |
| Race/Ethnicity, Customized White | 27 Participants |
| Region of Enrollment United States | 63 participants |
| Sex: Female, Male Female | 40 Participants |
| Sex: Female, Male Male | 22 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk | EG003 affected / at risk | EG004 affected / at risk | EG005 affected / at risk | EG006 affected / at risk | EG007 affected / at risk | EG008 affected / at risk | EG009 affected / at risk | EG010 affected / at risk | EG011 affected / at risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| deaths Total, all-cause mortality | 0 / 63 | 0 / 62 | 0 / 15 | 1 / 15 | 0 / 15 | 0 / 15 | 0 / 15 | 0 / 14 | 0 / 14 | 0 / 16 | 0 / 2 | 1 / 4 |
| other Total, other adverse events | 24 / 63 | 25 / 62 | 8 / 15 | 8 / 15 | 13 / 15 | 6 / 15 | 8 / 15 | 7 / 14 | 8 / 14 | 7 / 16 | 0 / 2 | 0 / 4 |
| serious Total, serious adverse events | 0 / 63 | 0 / 62 | 0 / 15 | 0 / 15 | 0 / 15 | 0 / 15 | 0 / 15 | 0 / 14 | 0 / 14 | 0 / 16 | 0 / 2 | 0 / 4 |